Registration for a live webinar on 'Phasing Out Animal Testing: A New Era for Pharmaceutical Innovation' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Innate Lymphoid Cells (ILCs)
- γδ T cells, MAIT cells, iNKT cells
- Innate immune system in the neonate - complement
- CD4+ T lymphocytes
- CD8+ T lymphocytes
- B lymphocytes
- Adaptive humoral immune system in the neonate
- Events impacting gut microbial composition and immune maturation
- Additional changes in the immune system during the ages of 1-5 years _x000B_
- Immune system in late childhood (6-19 years)
- Puberty associated changes in the immune system (1)
- Puberty associated changes in the immune system (2)
- Receptor expression and synthesis of hormones
- Effects of sex hormones on immune cell function
- Fundamentals of hormone signaling
- E2 signaling pathways
- Androgen signaling pathways
- T cell development and function
- Schematic of the architecture in thymus
- B cell development and antibody production
- Cytokine and chemokine production
- Epigenetic regulation
- Factors influencing the immune system development
Topics Covered
- IInnate immune system in the neonate
- Adaptive humoral immune system in the neonate
- Events impacting microbial composition and immune maturation
- Further changes in immune system during 1-5 years
- Immune system in late childhood (6-19 years)
- The fundamentals of hormone signaling
Links
Categories:
Therapeutic Areas:
Talk Citation
RS, J. (2025, February 27). Immune system across childhood 2 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved March 28, 2025, from https://doi.org/10.69645/ACWV5959.Export Citation (RIS)
Publication History
- Published on February 27, 2025
Financial Disclosures
- Prof. Jayshree RS has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Immune system across childhood 2
Published on February 27, 2025
25 min
A selection of talks on Reproduction & Development
Transcript
Please wait while the transcript is being prepared...
0:00
Welcome to Part 2 of the talk.
0:05
I will now talk about innate
lymphoid cells, ILC for short.
I had just alluded to these
cells while I was talking
about innate cellular
immune system in utero.
ILCs are lineage negative,
CD25 positive, CD127 positive,
IL2 receptor beta positive,
IL7 receptor alpha positive
lymphoid cells
generated in utero.
They play a pivotal
role in bridging
innate and adaptive immunity
and co evolution of
the gut microbiome.
ILCs are critical for life
mainly for the development
of normal tissue
microenvironment,
structure and composition.
They help the
neonate discriminate
between antigens to be
tolerated versus rejected.
ILCs interact with
their environment
through activating, inhibitory
and cytokine receptors.
ILCs mediate both pro and
anti-inflammatory responses
and can broadly be classified
into cytotoxic ILCs-
symbolizing natural
killer cells and
helper ILCs represented by
three subgroups namely:
ILC1s, ILC2s,
and ILC3s based on
their cytokine secretion
and transcription
factor profiles.
ILC1s express T-bet,
produce either interferon
gamma and TNF alpha,
or interferon gamma
alone and thereby are
subdivided into ILC1a
and 1b respectively.
ILC2s are GATA3 positive,
produce type 2 cytokines,
IL-4, IL-5,
lL-9, and IL-13,
and amphiregulin.
ILC3s express ROR gamma t,
produce IL-17a or IL-22.
TNF alpha, GM-CSF,
and gamma interferon,
and also have lymphoid
tissue-inducing ability.
In the newborn, in addition
to conventional T cells that